The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Pin to quick picksChamberlin Plc Regulatory News (CMH)

Share Price Information for Chamberlin Plc (CMH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.225
Bid: 1.15
Ask: 1.30
Change: -0.025 (-2.00%)
Spread: 0.15 (13.043%)
Open: 1.25
High: 1.25
Low: 1.225
Prev. Close: 1.25
CMH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hardman & Co Research: Chamberlin (CMH): Trading very difficult; forecasts lowered

6 Feb 2019 14:06

Hardman & Co Research Hardman & Co Research: Chamberlin (CMH): Trading very difficult; forecasts lowered 06-Feb-2019 / 14:05 GMT/BST


Hardman & Co Research: Trading very difficult; forecasts lowered

Prospects are very uncertain, and cost reduction measures are being implemented. However, the group continues to develop its product offering to the automobile turbocharger industry through development of its main operational facilities. The recent technical problems at the new machine shop are now resolved, and Chamberlin remains on track strategically. The recent disposal of Exidor has financially de-risked the group, and the shares remain attractively valued against the peer group on most methodologies.

Please click here for the full report:

https://www.hardmanandco.com/research/corporate-research/trading-very-difficult-forecasts-lowered/

To contact us: Hardman & Co 35 New Broad Street London EC2M 1NH www.hardmanandco.comFollow us on Twitter @HardmanandCo Contact: Paul Singer +44 20 7194 7622 ps@hardmanandco.com

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 21 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

773161 06-Feb-2019 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
15th Dec 20102:06 pmRNSHolding(s) in Company
24th Nov 20107:00 amRNSHalf Year Results
26th Oct 20107:00 amRNSMajor Contract Win
26th Oct 20107:00 amRNSMajor Contract Win
24th Sep 20107:00 amRNSPre close Trading Update
13th Sep 20101:30 pmRNSDirector/PDMR Shareholding
29th Jul 20103:24 pmRNSResult of AGM
29th Jul 20107:00 amRNSAGM Statement
13th Jul 20107:00 amRNSDirector/PDMR Shareholding
9th Jul 20107:00 amRNSDirector's Share Dealing
28th Jun 20107:00 amRNSDirector Share Dealing
16th Jun 201010:58 amRNSRe: Applicable Employee
14th Jun 20103:28 pmRNSDirector/PDMR Shareholding
10th Jun 20107:00 amRNSFinal Results
18th May 201012:22 pmRNSBoard Change
15th Mar 201011:41 amRNSDirector/PDMR Shareholding
24th Feb 20107:00 amRNSDirector/PDMR Shareholding
27th Nov 20097:00 amRNSHalf Yearly Report
23rd Oct 20097:00 amRNSTrading Update
23rd Jul 20092:37 pmRNSAGM Statement
30th Jun 20095:28 pmRNSPosting of Annual Report and Accounts
9th Jun 20093:08 pmRNSHolding(s) in Company
4th Jun 20097:00 amRNSFinal Results
16th Feb 20097:00 amRNSTrading Update
5th Jan 20097:00 amRNSChange of Adviser
19th Dec 20083:24 pmRNSDirectors Dealings
27th Nov 20087:00 amRNSInterim Results
18th Nov 20087:00 amRNSTrading Update
11th Nov 20087:00 amRNSChange of Nominated Adviser
8th Oct 200810:02 amRNSChange of Adviser Name
28th Jul 20083:17 pmRNSResult of AGM
28th Jul 20082:00 pmRNSAGM Statement
2nd Jul 20084:26 pmRNSDirectors' Dealings
1st Jul 20082:44 pmRNSFinal outcome of nuisance cla
6th Jun 200810:24 amRNSDividend Declaration
5th Jun 20087:00 amRNSFinal Results
25th Feb 20084:33 pmRNSDirector's Dealings
20th Dec 200711:28 amRNSDirector/PDMR Shareholding
27th Nov 200712:43 pmRNSDirector/PDMR Shareholding
27th Nov 20077:00 amRNSInterim Results
17th Aug 20078:25 amRNSAIM Rule 26
6th Aug 20079:47 amRNSChange of Name
31st Jul 20077:00 amRNSTotal Voting Rights
27th Jul 20073:46 pmRNSResult of AGM and Name Change
27th Jul 200712:41 pmRNSAGM Statement
6th Jul 200710:02 amRNSDirector's Dealings
7th Jun 200710:36 amRNSDirector's Dealings
7th Jun 20077:00 amRNSFinal Results
27th Mar 20072:54 pmRNSDirector's Dealing
31st Jan 20077:01 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.